• $1.4M
    Market Cap
  • -99.65%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
815,371
-67.70%
2.5M
+4,217.31%
58,465
N/A
N/A
N/A
Cost of Revenue
182,458
-87.58%
1.5M
+23.90%
1.2M
N/A
N/A
N/A
Gross Profit
632,913
-40.01%
1.1M
+193.61%
-1.1M
N/A
0
N/A
Sales and Marketing Expense
7.0M
-37.29%
11.2M
-23.96%
14.8M
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
-154,359
-92.08%
-1.9M
-52.80%
-4.1M
N/A
Depreciation and Amortization Expense
15,170
-97.93%
731,345
+1,564.53%
43,937
+550.73%
6,752
N/A
Total Operating Expenses
18.5M
-67.87%
57.5M
+64.85%
34.9M
+158.93%
13.5M
N/A
Operating Profit
-17.9M
-68.39%
-56.5M
+56.76%
-36.0M
+167.29%
-13.5M
N/A
Interest Income
2
-88.89%
18
N/A
N/A
N/A
N/A
N/A
Interest Expense
-800,000
+60.00%
-500,000
-25.55%
-671,625
N/A
N/A
N/A
Interest Income and Expense and Net
-799,998
+60.01%
-499,982
-25.56%
-671,625
N/A
0
N/A
Total Nonoperating Income and Expense
3.8M
+217.79%
-3.2M
+134.02%
-1.4M
N/A
N/A
N/A
Income before Taxes
-14.0M
-76.51%
-59.7M
+59.63%
-37.4M
+176.87%
-13.5M
N/A
Income Taxes
525
+100.05%
-1.0M
+8,199.69%
-12,593
-100.00%
3.2T
N/A
Extraordinary Items
N/A
N/A
3.5M
-76.19%
14.7M
N/A
N/A
N/A
Net Income
-14.0M
-76.09%
-58.7M
+56.89%
-37.4M
+178.76%
-13.4M
N/A
Net Income from Continuing Operations Applicable to Common
-15.5M
-73.63%
-58.9M
+57.44%
-37.4M
+176.78%
-13.5M
N/A
Basic EPS and Net Income
-16.56
-22.80%
-21.45
+879.45%
-2.19
+99.09%
-1.10
N/A
Diluted EPS and Net Income
-16.56
-22.80%
-21.45
+879.45%
-2.19
+99.09%
-1.10
N/A
Basic Weighted Average Shares
937,690
-65.85%
2.7M
-83.95%
17.1M
+39.44%
12.3M
N/A
Diluted Weighted Average Shares
937,690
-65.85%
2.7M
-83.95%
17.1M
+39.44%
12.3M
N/A
Balance Sheet
Cash and Cash Equivalents
3.6M
+456.84%
646,500
-85.80%
4.6M
-82.32%
25.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.6M
+456.84%
646,500
-85.80%
4.6M
-82.32%
25.8M
N/A
Total Current Assets
6.1M
+538.43%
950,267
-83.72%
5.8M
-77.77%
26.3M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
37,085
-41.04%
62,896
+3.70%
60,654
+330.51%
14,089
N/A
Total Long-Term Assets
262,085
-27.78%
362,896
-14.97%
426,767
+2,929.08%
14,089
N/A
Total Assets
24.9M
-11.55%
28.2M
-67.80%
87.5M
+232.64%
26.3M
N/A
Income Taxes Payable
80,000
+100.00%
40,000
-98.70%
3.1M
N/A
N/A
N/A
Total Short-Term Debt
500,000
N/A
N/A
N/A
9.6M
N/A
N/A
N/A
Total Current Liabilities
9.1M
-50.05%
18.3M
+6.40%
17.2M
+338.25%
3.9M
N/A
Total Long-Term Debt
247,197
-95.06%
5.0M
+4,106.74%
118,857
N/A
N/A
N/A
Total Long-Term Liabilities
24,362
-43.46%
43,089
-99.32%
6.3M
N/A
N/A
N/A
Total Liabilities
9.2M
-50.67%
18.6M
-15.11%
21.9M
+457.75%
3.9M
N/A
Retained Earnings
-131.2M
+13.43%
-115.7M
+103.72%
-56.8M
+193.07%
-19.4M
N/A
Total Stockholders Equity
15.8M
+84.54%
8.5M
+252.49%
-5.6M
-125.02%
22.4M
N/A
Total Shares Outstanding
1.6M
-86.73%
11.8M
-47.35%
22.3M
+46.24%
15.3M
N/A
Cash Flow
Cash from Operating Activities
-9.7M
-7.79%
-10.5M
-22.72%
-13.6M
+56.12%
-8.7M
N/A
Capital Expenditures
N/A
N/A
28,471
+762.76%
3,300
-64.66%
9,339
N/A
Cash from Investing Activities
N/A
N/A
-28,471
-99.67%
-8.6M
+92,512.00%
-9,339
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.5M
+114.33%
6.7M
+551.47%
1.0M
-96.82%
32.5M
N/A
Financials Ratio
Gross Margin
77.62%
+85.70%
41.80%
+102.17%
-1,927.93%
N/A
N/A
N/A
Operating Margin
-2,190.03%
-2.14%
-2,237.96%
-96.37%
-61,634.47%
N/A
N/A
N/A
Return on Assets
-52.84%
-47.91%
-101.45%
+54.35%
-65.73%
N/A
N/A
N/A
Return on Equity
-115.46%
-97.11%
-3,991.77%
+795.57%
-445.73%
N/A
N/A
N/A
Revenue Growth
-67.70%
-101.61%
4,217.31%
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.66
+1,177.12%
0.05
-84.69%
0.34
N/A
N/A
N/A
Cash Ratio
0.39
+1,016.15%
0.04
-86.67%
0.26
N/A
N/A
N/A
Debt-to-Equity Ratio
0.05
N/A
N/A
N/A
-1.74
N/A
N/A
N/A
Debt-to-Assets Ratio
0.03
N/A
N/A
N/A
0.11
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow